ATC Group: J06BB05 Rabies immunoglobulin

Position of J06BB05 in the ATC hierarchy

Level	Code	Title
1	J	Antiinfectives for systemic use
2	J06	Immune sera and immunoglobulins
3	J06B	Immunoglobulins
4	J06BB	Specific immunoglobulins
5	J06BB05	Rabies immunoglobulin

Active ingredients in J06BB05

Active Ingredient
Human rabies immunoglobulin
Human rabies immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against rabies virus. Human Rabies Immunoglobulin must always be used in combination with a rabies vaccine.

Related product monographs

Document	Type	Information Source
HYPERRAB Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

United States medicines

• HYPERRAB
• IMOGAM RABIES-HT

Medicines classified under this ATC code globally

Austria (AT)

• BERIRAB

Canada (CA)

• HYPERRAB
• IMOGAM RABIES PASTEURIZED
• KAMRAB

Estonia (EE)

• BERIRAB
• IMOGAM RABIES

France (FR)

• IMOGAM RAGE

Hong Kong (HK)

• BERIRAB
• HYPERRAB

Israel (IL)

• BERIRAB
• KAMRAB

Lithuania (LT)

• IMOGAM RABIES

Romania (RO)

• KAMRAB

Singapore (SG)

• HYPERRAB

South Africa (ZA)

• RABIGAM

Spain (ES)

• IMOGAM RABIA

Turkey (TR)

• ALBIES
• EQUIRAB

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.